Verus Capital Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Sell |
6,985
-1,040
| -13% | -$287K | 0.16% | 91 |
|
|
2025
Q1 | $2.13M | Buy |
8,025
+11
| +0.1% | +$2.92K | 0.2% | 76 |
|
|
2024
Q4 | $1.86M | Buy |
8,014
+261
| +3% | +$60.6K | 0.17% | 89 |
|
|
2024
Q3 | $1.71M | Sell |
7,753
-68
| -0.9% | -$15K | 0.16% | 90 |
|
|
2024
Q2 | $1.54M | Sell |
7,821
-110
| -1% | -$21.6K | 0.15% | 101 |
|
|
2024
Q1 | $1.71M | Sell |
7,931
-160
| -2% | -$34.4K | 0.19% | 79 |
|
|
2023
Q4 | $1.7M | Buy |
8,091
+115
| +1% | +$24.2K | 0.21% | 73 |
|
|
2023
Q3 | $1.6M | Buy |
7,976
+160
| +2% | +$32K | 0.22% | 71 |
|
|
2023
Q2 | $1.45M | Sell |
7,816
-35
| -0.4% | -$6.49K | 0.21% | 76 |
|
|
2023
Q1 | $1.5M | Buy |
7,851
+175
| +2% | +$33.5K | 0.24% | 71 |
|
|
2022
Q4 | $1.29M | Buy |
7,676
+140
| +2% | +$23.5K | 0.24% | 70 |
|
|
2022
Q3 | $1.34M | Buy |
7,536
+4,001
| +113% | +$709K | 0.25% | 62 |
|
|
2022
Q2 | $1.55M | Sell |
3,535
-4,016
| -53% | -$1.77M | 0.3% | 56 |
|
|
2022
Q1 | $1.59M | Buy |
+7,551
| New | +$1.59M | 0.25% | 69 |
|
|
2020
Q1 | $1.25M | Buy |
7,245
+67
| +0.9% | +$11.6K | 0.39% | 44 |
|
|
2019
Q4 | $1.44M | Buy |
+7,178
| New | +$1.44M | 0.47% | 37 |
|